key: cord-0899704-wgqbv9ix
authors: Qian, Sarah; Faithfull, Jennie; Sangster, Philippa; Butler, Gary; Srirangalingam, Umasuthan
title: Klinefelter syndrome—Considerations in management during the SARS‐CoV‐2 pandemic
date: 2021-07-26
journal: Clin Endocrinol (Oxf)
DOI: 10.1111/cen.14553
sha: 06d901eeb474d135ddc9c6b1435fc6629086e7a0
doc_id: 899704
cord_uid: wgqbv9ix

nan

To the Editor,

The current unprecedented severe acute respiratory syndrome coronavirus 2 pandemic (SARS-CoV-2) has presented a multitude of challenges to healthcare systems and led to disease-specific management recommendations, with several published in this journal.

We would like to highlight such considerations for patients with Klinefelter syndrome (KS). Whilst we are not aware of a specific study addressing SARS-CoV-2 in a KS population, its associated features have been independently linked to increased susceptibility to infection and managing this constellation of risks warrants discussion.

Men appear more susceptible to severe SARS-CoV-2 infection, though the precise mechanisms are debated. Hypogonadism is of course the cardinal feature of KS and several parallel lines of evidence support the notion that low testosterone can increase susceptibility to SARS-CoV-2 infection. For example, older men with hypogonadism have an increased incidence of acute respiratory distress syndrome, respiratory failure and mortality following influenza and testosterone replacement has been shown to reduce airway inflammation in asthma. 1 It has been suggested that the im- Effective management of KS requires a multidisciplinary approach from an early age. 5 The outpatient KS service at our institution, 'KF-Xtra', provides multidisciplinary, holistic care for patients and their families, with support from paediatric, endocrinology, andrology, fertility and psychology colleagues. Clinics have been modified to run remotely with telephone and video calls, however, we aim to provide continuity with the same staff. We have adapted the service to address specific concerns relating to the pandemic such as safety and compliance with the regulation in the home, school and workplace as well as managing feelings of isolation and anxiety. Elements of medical monitoring (e.g., biochemical monitoring for testosterone and metabolic assessments) have been deferred or devolved to local primary care services.

Population-based studies in KS subjects to define the specific risk posed by the SARS-CoV-2 virus and mechanistic studies to understand the aetiological factors involved would be of interest. We do not advocate changes in therapy based on theoretical risks or benefits in the absence of clear data, however, physicians need to be aware of the complex interplay of risk factors alongside psychosocial challenges in KS to provide effective treatment and support. Whilst the current pandemic has limited the provision of routine healthcare, it has unexpectedly presented an opportunity to innovate and trial new models of healthcare delivery. Flexible multidisciplinary input, delivered across various platforms and tailored to the individual patient is crucial to provide holistic care in this cohort.

Why does COVID-19 kill more elderly men than women? Is there a role for testosterone? Andrology

Sex differences in immune responses

Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males

Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis

Clinical review: Klinefelter syndrome-A clinical update

The authors would like to thank Professor Sine McDougall, Bournemouth University. Dr. Jennie Faithful received a grant from Besin Healthcare to fund initial work in the KF-Xtra clinic.